Folate and brain function in the elderly

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 7, Issue 6, 2004, Pages 659-664

  D'Anci, Kristen E ^a,c   Rosenberg, Irwin H ^a,b  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS UNIVERSITY   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Dementia; Depression; Elderly; Folate; Folic acid; Homocysteine

Indexed keywords

ANTIDEPRESSANT AGENT; CYANOCOBALAMIN; FLAVINE ADENINE NUCLEOTIDE; FOLIC ACID DERIVATIVE; PYRIDOXAL 5 PHOSPHATE; TETRAHYDROFURAN;

ALZHEIMER DISEASE; BLOOD CELL; BRAIN FUNCTION; BRAIN TISSUE; COGNITIVE DEFECT; CYANOCOBALAMIN DEFICIENCY; DEMENTIA; DEPRESSION; DIET SUPPLEMENTATION; HUMAN; MOOD; REVIEW;

AGED; BRAIN; COGNITION; DEMENTIA; DEPRESSION; ERYTHROCYTES; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; HUMANS; MALE; VITAMIN B 12 DEFICIENCY;

EID: 14844291565     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075197-200411000-00011     Document Type: Review

References (48)

1. Rosenberg IH. B vitamins, homocysteine, and neurocognitive function. Nutr Rev 2001; 59:369-373.
2. Bottiglieri T, Crellin RF, Reynolds EH. Folate and neuropsychiatry. In: Bailey LB, editor. Folate in health and disease. New York: Marcel Dekker, Inc; 1995. pp. 435-462.
3. Serot JM, Christmann D, Dubost T, et al. CSF-folate levels are decreased in late-onset AD patients. J Neural Transm 2001; 108:93-99.
4. Bottiglieri T, Reynolds EH. Folate in CSF and age. J Neural Neurosurg Psychiatry 2000; 69:562-563.
5. Lindeman RD, Romero LJ, Koehler KM, et al. Serum vitamin B12, C, and folate concentrations in the New Mexico Elder Health Survey: correlations with cognitive and affective functions. J Am Coll Nutr 2000; 19:68-76.
6. Bottiglieri T, Laundy M, Crellin R, et al. Homocysteine, folate, methylation, and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry 2000; 69:228-232.
7. Wagner C. Biochemical role of folate in cellular metabolism. In: Bailey LB, editor. Folate in health and disease. New York: Marcel Dekker, lnc; 1995. pp. 23-42.
8. Selhub J, Jacques PF, Bostom AG, et al. Relationship between plasma homocysteine and vitamin status in the Framingham study population: impact of folic acid fortification. Public Health Rev 2000; 28:117-145.
9. Choumenkovitch SF, Selhub J, Wilson PW, et al. Folic acid intake from fortification in United States exceeds predictions. J Nutr 2002; 132:2792-2798.
10. Shane B. Folate chemistry and metabolism. In: Bailey LB, editor. Folate in health and disease. New York: Marcel Dekker, Inc; 1995. pp. 1-22.
11. Alpert M, Suva RR, Pouget ER. Prediction of treatment response in geriatric depression from baseline folate level: interaction with an SSRI or a tricyclic antidepressant. J Clin Psychopharmacol 2003; 23:309-313. Strong support for hypothesized relationship between folate and monoamines in depression.
12. Selhub J, Bagley LC, Miller J, Rosenberg IH. B vitamins, homocysteine, and neurocognitive function in the elderly. Am J Clin Nutr 2000; 71:6143-6203.
13. Raskind MA. The clinical interface of depression and dementia. J Clin Psychiatry 1998; 59 (Suppl):9-12.
14. Alpert JE, Mischoulon D, Nierenberg AA, Fava M. Nutrition and depression: focus on folate. Nutrition 2000; 16:544-546.
15. Fava M, Borus JS, Alpert JE, et al. Folate, vitamin B12, and homocysteine in major depressive disorder. Am J Psychiatry 1997; 154:426-428.
16. Bottiglieri T. Folate, vitamin B12, and neuropsychiatric disorders. Nutr Rev 1996; 54:382-390.
17. Morris MS, Fava M, Jacques PF, et al. Depression and folate status in the US population. Psychother Psychosom 2003; 72:80-87. This paper convincingly demonstrates the importance of folate in depression independent of potentially confounding variables such as socio-economic status, ethnicity, and alcohol use.
18. Tolmunen T, Voutilainen S, Hintikka J, et al. Dietary folate and depressive symptoms are associated in middle-aged Finnish men. J Nutr 2003; 133:3233-3236. This study provides additional evidence for association of low-folate status and depression.
19. Alpert JE, Fava M. Nutrition and depression: the role of folate. Nutr Rev 1997; 55:145-149.
20. Penninx BWJH, Guralnik JM, Ferrucci L, et al. Vitamin B12 deficiency and depression in physically disabled older women: epidemiologic evidence from the Women's Health and Aging Study. Am J Psychiatry 2000; 157:715-721.
21. Tiemeier H, van Tuijl HR, Hofman A, et al. Vitamin B12, folate, and homocysteine in depression: the Rotterdam Study. Am J Psychiatry 2002; 159:2099-2101.
22. Bryan J, Calvaresi E, Hughes D. Short-term folate, vitamin B12 or vitamin B6 supplementation slightly affects memory performance but not mood in women of various ages. J Nutr 2002; 132:1345-1356.
23. Coppen A, Bailey JE. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomized, placebo-controlled trial. J Affect Disord 2000; 60:121-130.
24. Young SN. The use of diet and dietary components in the study of factors controlling affect in humans: a review. J Psychiatry Neurosci 1993; 18:235-244.
25. Rosenberg IH, Miller JW. Nutritional factors in physical and cognitive functions of elderly people. Am J Clin Nutr 1992; 55:1237S-1243S.
26. Morris MS, Jacques PF, Rosenberg IH, Selhub J. Hyperhomocysteinemia associated with poor recall in the third National Health and Nutrition Examination Survey. Am J Clin Nutr 2001; 73:927-933.
27. Ellinson M, Thomas J, Patterson A. A critical evaluation of the relationship between serum vitamin B12, folate and total homocysteine with cognitive impairment in the elderly. J Hum Nutr Dietet 2004; 17:371-383. Cochrane Dementia and Cognitive Improvement Group, Oxford review four studies examining B-vitamin status, homocysteine, mood, and cognition.
28. Morris MS. Folate, homocysteine, and neurological function. Nutr Clin Care 2002; 5:124-132.
29. Morris MS. Homocysteine and Alzheimer's disease. Lancet Neurol 2003; 2:425-428. Concise recent review of homocysteine and Alzheimer's disease - includes epidemiological data.
30. Nilsson K, Gustafson L, Hultberg B. Plasma homocysteine concentration relates to the severity but not the duration of Alzheimer's disease. Int J Geriatr Psychiatry 2004; 19:666-672.
31. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002; 346:476-483.
32. Miller JW, Green R, Ramos MI, et al. Homocysteine and cognitive function in the Sacramento Area Latino Study on Aging. Am J Clin Nutr 2003; 78:441-447.
33. Teunissen CE, Blom AH, Van Boxtel MP, et al. Homocysteine: a marker for cognitive performance? A longitudinal follow-up study. J Nutr Health Aging 2003; 7:153-159.
34. Quadri P, Fragiacomo C, Pezzati R, et al. Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am J Clin Nutr 2004; 80:114-122. This study shows the relationship between folate and cognitive impairment, and suggests folate depletion may precede more severe impairment.
35. Mizrahi EH, Jacobsen DW, Debanne SM, et al. Plasma total homocysteine levels, dietary vitamin B6 and folate intake in AD and healthy aging. J Nutr Health Aging 2003; 7:160-165.
36. Engelborghs S, Vloeberghs E, Maertens K, et al. Correlations between cognitive, behavioural and psychological findings and levels of vitamin B12 and folate in patients with dementia, Int J Geriatr Psychiatry 2004; 19:365-370. Expands findings of low folate and severity of dementia in frontotemporal dementia patients.
37. Snowdon DA, Tully CL, Smith CD, et al. Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun Study. Am J Clin Nutr 2000; 71:993-998.
38. Brouwer IA, van Dusseldorp M, Thomas CM, et al. Low-dose folic acid supplementation decreases plasma homocysteine concentrations: a randomized trial. Am J Clin Nutr 1999; 69:99-104.
39. Aisen PS, Egelko S, Andrews H, et al. A pilot study of vitamins to lower plasma homocysteine levels in Alzheimer disease. Am J Geriatr Psychiatry 2003; 11:246-249. This pilot study is of particular importance in that the researchers are investigating the effects of B-vitamin supplementation in existing Alzheimer's patients and plan to follow up with cognitive scores.
40. Sommer BR, Hoff AL, Costa M. Folic acid supplementation in dementia: a preliminary report. J Geriatr Psychiatry Neurol 2003; 16:156-159.
41. Nilsson K, Gustafson L, Hultberg B. Improvement of cognitive functions after cobalamin/folate supplementation in elderly patients with dementia and elevated plasma homocysteine. Int J Geriatr Psychiatry 2001; 16:609-614.
42. Wald DS, Bishop L, Wald NJ, et al. Randomized trial of folic acid supplementation and serum homocysteine levels. Arch Intern Med 2001; 161:695-700.
43. Tucker KL, Scott TM, Folstein M. Homocysteine, cerebrovascular disease, cognitive function and aging. In: O'Brien J, Ames D, Gustafson L, et al., editors. Cerebrovascular disease, cognitive impairment and dementia. 2nd ed. London: Martin Dunitz; 2004. pp. 181-193. Valuable contemporary review.
44. Reynolds EH. Folic acid, vitamin B12, and the nervous system: historical aspects. In: Botez MI, Reynolds EH, editors. Folic acid in neurology, psychiatry, and internal medicine. New York: Raven Press; 1979. pp. 1-5.
45. Reynolds EH. Benefits and risks of folic acid to the nervous system. J Neurol Neurosurg Psychiatry 2002; 72:567-571.
46. Bailey LB. Folate requirements and dietary recommendations. In: Bailey LB, editor. Folate in health and disease. New York: Marcel Dekker, Inc; 1995. pp. 123-151.
47. Food and Drug Administration, DHHS. Food labeling: health claims and label statements; folate and neural tube defects. Fed Reg 1993; 58:53254-53295.
48. Bailey LB. Folic acid supplements and fortification affect the risk for neural tube defects, vascular disease and cancer: evolving science. J Nutr 2003; 133:1961S-1968S.